{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:10:08Z","timestamp":1792113008378,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.genhosppsych.2019.01.003","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T02:05:03Z","timestamp":1547517903000},"page":"23-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["The effect of cognitive behavioral therapy on the circulating proinflammatory cytokines of fibromyalgia patients: A pilot controlled clinical trial"],"prefix":"10.1016","volume":"57","author":[{"given":"Mozhdeh","family":"Zabihiyeganeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedigheh","family":"Vafaee Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azade","family":"Amini Kadijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davod","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl","family":"Bagherifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2984-3488","authenticated-orcid":false,"given":"Masoud","family":"Janbozorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia","volume":"17","author":"Queiroz","year":"2013","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/ijcp.12757","article-title":"Fibromyalgia: management strategies for primary care providers","volume":"70","author":"Arnold","year":"2016","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0015","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00002508-199803000-00011","article-title":"Myofascial pain syndrome and fibromyalgia: a critical assessment and alternate view","volume":"14","author":"Aronoff","year":"1998","journal-title":"Clin J Pain"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0025","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/j.1532-2149.2014.00453.x","article-title":"Fibromyalgia syndrome: a somatoform disorder?","volume":"18","author":"H\u00e4user","year":"2014","journal-title":"Eur J Pain"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0030","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ejp.1121","article-title":"Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome\u2013a systematic review and meta-analysis of randomized controlled trials","volume":"22","author":"Bernardy","year":"2018","journal-title":"Eur J Pain"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2147\/JPR.S128508","article-title":"Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma","volume":"10","author":"B\u00e4ckryd","year":"2017","journal-title":"J Pain Res"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0040","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3985154","article-title":"Plasma cytokine levels in fibromyalgia and their response to 15\u202fweeks of progressive resistance exercise or relaxation therapy","volume":"2018","author":"Ernberg","year":"2018","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0045","first-page":"106","article-title":"Higher levels of pro-inflammatory and lower levels of anti-inflammatory cytokines are present in fibromyalgia patients: abstract number: 67","volume":"67","author":"Katz","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0050","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0055","series-title":"Diagnostic and statistical manual of mental disorders","author":"Edition","year":"2013"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0060","first-page":"167","article-title":"Effects of vitamin D optimization on quality of life of patients with fibromyalgia: a randomized controlled trial","volume":"32","author":"Mirzaei","year":"2018","journal-title":"Med J IR Iran (MJIRI)"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jneuroim.2015.02.002","article-title":"Evidence of different mediators of central inflammation in dysfunctional and inflammatory pain\u2014interleukin-8 in fibromyalgia and interleukin-1\u03b2 in rheumatoid arthritis","volume":"280","author":"Kosek","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.sjpain.2015.04.027","article-title":"Cognitive behaviour therapy in women with fibromyalgia: a randomized clinical trial","volume":"9","author":"Karlsson","year":"2015","journal-title":"Scand J Pain"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/da.20070","article-title":"Psychometric properties of a Persian-language version of the Beck Depression Inventory-second edition: BDI-II-PERSIAN","volume":"21","author":"Ghassemzadeh","year":"2005","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0080","first-page":"136","article-title":"Psychometric properties of the Persian version of Beck Anxiety Inventory (BAI)","volume":"66","author":"Kaviani","year":"2008","journal-title":"Tehran Univ Med J"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00296-013-2929-3","article-title":"The validity and reliability of the Persian version of the Revised Fibromyalgia Impact Questionnaire","volume":"34","author":"Parsa","year":"2014","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.genhosppsych.2019.01.003_bb0090","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00296-013-2883-0","article-title":"Validation of a Persian version of the Fibromyalgia Impact Questionnaire (FIQ-P)","volume":"34","author":"Bidari","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jneuroim.2015.11.011","article-title":"IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients","volume":"290","author":"Mendieta","year":"2016","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0105","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/rheumatology\/40.7.743","article-title":"Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study","volume":"40","author":"Wallace","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0110","first-page":"16","article-title":"Reduced pro-inflammatory cytokines after eight weeks of low-dose naltrexone for fibromyalgia","volume":"5","author":"Parkitny","year":"2017","journal-title":"Biomedicine"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneuroim.2015.06.004","article-title":"The effect of proinflammatory cytokines in Cognitive Behavioral Therapy","volume":"285","author":"Moreira","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0120","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0004867417701996","article-title":"Cognitive behaviour therapy and inflammation: a systematic review of its relationship and the potential implications for the treatment of depression","volume":"51","author":"Lopresti","year":"2017","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0125","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/0004867418757919","article-title":"Cognitive behaviour therapy and inflammation: a systematic review of its relationship and the potential implications for the treatment of depression","volume":"52","author":"Schmidt","year":"2018","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0130","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1586\/eci.10.64","article-title":"Duloxetine for the treatment of fibromyalgia","volume":"6","author":"Wright","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.genhosppsych.2019.01.003_bb0135","first-page":"99","article-title":"Duloxetine for the management of fibromyalgia syndrome","volume":"2","author":"Scholz","year":"2009","journal-title":"J Pain Res"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834318303876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834318303876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:50:14Z","timestamp":1759013414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834318303876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":27,"alternative-id":["S0163834318303876"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2019.01.003","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of cognitive behavioral therapy on the circulating proinflammatory cytokines of fibromyalgia patients: A pilot controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2019.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}